Dr. Castaneda, MD is a practicing Internist in San Jose, CA. Dr. Castaneda graduated from Stanford University School of Medicine in 2014. He completed a residency at Stanford Medical Center. Dr. Castaneda is affiliated with Kaiser Permanente Medical Center.
- Stanford University School of Medicine, MD
- Harvard University, MDiv
- Bethany Bible College, BA
- Published on 6/22/2016
Rolnick J, Downing NL, Shepard J, Chu W, Tam J, Wessels A, Li R, Dietrich B, Rudy M, Castaneda L, Shieh L. Validation of Test Performance and Clinical Time Zero for an Electronic Health Record Embedded Severe Sepsis Alert. Appl Clin Inform. 2016; 7(2):560-72. PMID: 27437061.
- Published on 3/13/2014
Cheng JC, Graber MS, Hsu FM, Tsai CL, Castaneda L, Lee JM, Chang DT, Koong AC. High serum levels of vascular endothelial growth factor-A and transforming growth factor-ß1 before neoadjuvant chemoradiotherapy predict poor outcomes in patients with esophageal squamous cell carcinoma receiving combined modality therapy. Ann Surg Oncol. 2014 Jul; 21(7):2361-8. PMID: 24623035.
- Published on 1/1/2014
Cheng JC, Graber MS, Hsu FM, Tsai CL, Castaneda L, Lee JM, Chang DT, Koong AC. High Serum Levels of Vascular Endothelial Growth Factor-A and Transforming Growth Factor-ß1 Before Neoadjuvant Chemoradiotherapy Predict Poor Outcomes in Patients with Esophageal Squamous Cell Carcinoma Receiving Combined Modality Therapy. Ann Surg Oncol. 2014; 21(7):2361-8.